At ages 23-27, those who had earlier treatment had less disability, said Sifat Sharmin, PhD, of the University of Melbourne ...

"We found that patients who were treated with high-efficacy disease-modifying therapies during the initial phases of their disease benefited the most compared to patients who were not treated," Dr.